Congenital toxoplasmosis: Late pregnancy infections detected by neonatal screening and maternal serological testing at delivery

Paediatric and Perinatal Epidemiology

Volumn 21, Issue 6, 2007, Pages 525-531

  Lago, Eleonor G ^a   Neto, Eurico C ^b   Melamed, Jacobo ^c   Rucks, Ana P ^a   Presotto, Carolina ^a   Coelho, Jaqueline C ^a   Parise, Cassiana ^c   Vargas, Paula R ^d   Goldbeck, Ana S ^e   Fiori, Renato M ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Centro de Triagem Neonatal (Center for Neonatal Screening)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Secretaria Da Saúde Do Município de Porto Alegre Municipal Public Health Department

^e Lab Estadual de Referencia para Rastreamento Neonatal (Neonatal Screening State Ref Laboratory)   (Brazil)

Author keywords

Congenital toxoplasmosis; Screening

Indexed keywords

IMMUNOGLOBULIN M;

ANALYTIC METHOD; ARTICLE; BRAZIL; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DELIVERY; FEMALE; FLUOROMETRY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRENATAL CARE; PREVALENCE; PUBLIC HEALTH; SCREENING; SEROLOGY; TOXOPLASMA GONDII;

BRAZIL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDIES; TOXOPLASMOSIS, CONGENITAL;

EID: 35348987608     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2007.00869.x     Document Type: Article

References (40)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004 363 : 1965 1976.
2. Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. New England Journal of Medicine 1974 290 : 1110 1116.
3. Couvreur J, Thulliez P, Daffos F, Aufrant C, Bompard Y, Gesquière A, et al. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagnosis and Therapy 1993 8 : 45 50.
4. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. New England Journal of Medicine 1988 318 : 271 275.
5. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. New England Journal of Medicine 1994 331 : 695 699.
6. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstetrics and Gynecology 2001 97 : 296 300.
7. Kaiser K, Van Loon AM, Pelloux H, Ferrandiz J, Picot S, Wallace P, et al. Multicenter proficiency study for detection of Toxoplasma gondii in amniotic fluid by nucleic acid amplification methods. Clinica Chimica Acta 2007 375 : 99 103.
8. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenber B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. New England Journal of Medicine 1994 330 : 1858 1863.
9. McAuley J, Boyer KM, Patel D, Mets M, Suvsher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clinical Infectious Diseases 1994 18 : 38 72.
10. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clinical Infectious Diseases 2006 42 : 1383 1394.
11. Eichenwald HR. A study of congenital toxoplasmosis with particular emphasis on clinical manifestations, sequelae and therapy. In : Human Toxoplasmosis. Editor : Siim JC. Copenhagen : Munksgaard, 1959 pp. 41 49.
12. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980 66 : 767 774.
13. Koppe JG, Loewer-Sieger DH, Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986 1 : 254 255.
14. Koppe JG, Meenken C. Congenital toxoplasmosis, later relapses and treatment. Acta Paediatrica 1999 88 : 667 670.
15. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004 113 : 1567 1572.
16. Breugelmans M, Naessens A, Foulon W. Prevention of toxoplasmosis during pregnancy - an epidemiologic survey over 22 consecutive years. Journal of Perinatal Medicine 2004 32 : 211 214.
17. Ambroise-Thomas P, Schweitzer M, Pinon JM, Thiebaugeorges O. La prévention de la toxoplasmose congénitale en France. Évaluation des risques. Résultats et perspectives du dépistage anténatal et du suivi du nouveau-né. Bulletin de l'Académie Nationale de Médecine 2001 185 : 665 688.
18. Naessens A. Screening for toxoplasmosis during pregnancy: the situation in Belgium. Archives de Pédiatrie 2003 10 (Suppl. 1 18.
19. Petersen E, Eaton R. Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples. Acta Paediatrica Supplement 1999 88 : 36 39.
20. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999 353 : 1834 1837.
21. Paul M, Petersen E, Pawlowski Z, Szczapa J. Neonatal screening for Toxoplasma gondii in Poznán region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatric Infectious Disease Journal 2000 19 : 30 36.
22. Paul M, Petersen E, Szczapa J. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznán region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. Journal of Clinical Microbiology 2001 39 : 1912 1916.
23. Lynfield R, Hsu HW, Guerina NG. Screening methods for congenital toxoplasmosis and risk of disease. Lancet 1999 353 : 1899 1900.
24. Ambroise-Thomas P. Toxoplasmose congénitale: les différentes stratégies préventives. Archives de Pédiatrie 2003 10 : 12 14.
25. Gilbert RE, Peckham C. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? Journal of Medical Screening 2002 9 : 135 141.
26. Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, et al. Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scandinavian Journal of Infectious Diseases 1995 27 : 265 272.
27. Binquet C, Wallon M, Quantin C, Gadreau M, Peyron F. Evaluation de stratégies de prévention de la toxoplasmose congénitale: revue critique des études médico-économiques. Revue d'Épidémiologie et de Santé Publique 2002 50 : 475 487.
28. Varella IS, Wagner MB, Darela AC, Nunes LM, Müller RW. Prevalência de soropositividade para toxoplasmose em gestantes [Sero-prevalence of toxoplasmosis in pregnant women]. In Portuguese. Jornal de Pediatria (Rio de Janeiro) 2003 79 : 69 74.
29. Neto EC, Anele E, Rubim R, Brites A, Schulte J, Becker D, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. International Journal of Epidemiology 2000 29 : 941 947.
30. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerging Infectious Diseases 2003 9 : 55 62.
31. Hartup C, Johnson JD, Holliman RE. The investigation of toxoplasma infection associated with pregnancy. Journal of Infection 1997 35 : 47 54.
32. Eaton RB, Petersen E, Seppänen H, Tuuminen T. Multicenter evaluation of a fluorimetric immunocapture assay to detect Toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. Journal of Clinical Microbiology 1996 34 : 3147 3150.
33. Sørensen T, Spenter J, Jaliashvili I, Christiansen M, Nørgaard-Pedersen B, Petersen E. Automated time-resolved immunofluorimetric assay for Toxoplasma gondii-specific IgM and IgA antibodies: study of more than 130 0 00 filter-paper blood-spot samples from newborns. Clinical Chemistry 2002 48 : 1981 1986.
34. Tissot-Dupont D, Fricker-Hidalgo H, Brenier-Pinchard MP, Bost-Bru C, Ambroise-Thomas P, Pelloux H. Usefulness of Western Blot in serological follow-up of newborns suspected of congenital toxoplasmosis. European Journal of Clinical Microbiology and Infectious Diseases 2003 22 : 122 125.
35. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999 353 : 1899 1900.
36. Desmonts G, Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bulletin of the New York Academy of Medicine 1974 50 : 146 159.
37. Wirden M, Botterel F, Romand S, Ithier G, Bourée P. Intérêt du dépistage en post-partum de la toxoplasmose congénitale après primo-infection maternelle en fin de grossesse. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction 1999 28 : 566 567.
38. Wallon M, Franck J, Romand S, Peyron S, Dumon H, Thulliez P. Intérêt de la sérologie toxoplasmique à l'accouchement chez les femmes séronégatives pendant la grossesse. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction 2001 30 : 697 699.
39. Chemla C, Villena L, Aubert D, Hornoy P, Dupouy D, Leroux B, et al. Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis. Clinical and Diagnostic Laboratory Immunology 2002 9 : 489 490.
40. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In : Infectious Diseases of the Fetus and Newborn Infant, 6th edn. Editors : Remington JS, Klein JO, Wilson CB, Baker CJ. Philadelphia, PA : Elsevier-Saunders, 2006 pp. 948 1091.